These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15723614)

  • 21. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential.
    Bogoyevitch MA; Boehm I; Oakley A; Ketterman AJ; Barr RK
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):89-101. PubMed ID: 15023353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation.
    Troy CM; Rabacchi SA; Xu Z; Maroney AC; Connors TJ; Shelanski ML; Greene LA
    J Neurochem; 2001 Apr; 77(1):157-64. PubMed ID: 11279271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JNK: bridging the insulin signaling and inflammatory pathway.
    Liu G; Rondinone CM
    Curr Opin Investig Drugs; 2005 Oct; 6(10):979-87. PubMed ID: 16259218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities.
    Mehan S; Meena H; Sharma D; Sankhla R
    J Mol Neurosci; 2011 Mar; 43(3):376-90. PubMed ID: 20878262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and Synthesis of a Mitochondrial-Targeted JNK Inhibitor and Its Protective Effect on Parkinson's Disease Phenotypes.
    Zhou Z; Zhang D; Du F; An W; Ge J; Yu C; Yang N; Zhang C; Lim K; Li L
    Chembiochem; 2023 Jul; 24(13):e202200748. PubMed ID: 36946263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo.
    Saporito MS; Thomas BA; Scott RW
    J Neurochem; 2000 Sep; 75(3):1200-8. PubMed ID: 10936203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells.
    Su JL; Lin MT; Hong CC; Chang CC; Shiah SG; Wu CW; Chen ST; Chau YP; Kuo ML
    Carcinogenesis; 2005 Jan; 26(1):1-10. PubMed ID: 15217905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways.
    Lee DY; Oh YJ; Jin BK
    Glia; 2005 Aug; 51(2):98-110. PubMed ID: 15789435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases.
    Saporito MS; Hudkins RL; Maroney AC
    Prog Med Chem; 2002; 40():23-62. PubMed ID: 12516522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that neuronal Notch-1 promotes JNK/c-Jun activation and cell death following ischemic stress.
    Cheng YL; Choi Y; Seow WL; Manzanero S; Sobey CG; Jo DG; Arumugam TV
    Brain Res; 2014 Oct; 1586():193-202. PubMed ID: 25168760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed-lineage kinases: a target for the prevention of neurodegeneration.
    Wang LH; Besirli CG; Johnson EM
    Annu Rev Pharmacol Toxicol; 2004; 44():451-74. PubMed ID: 14744254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage.
    Nijboer CH; Bonestroo HJ; Zijlstra J; Kavelaars A; Heijnen CJ
    Neurobiol Dis; 2013 Jun; 54():432-44. PubMed ID: 23376684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.
    Pan J; Wang G; Yang HQ; Hong Z; Xiao Q; Ren RJ; Zhou HY; Bai L; Chen SD
    Mol Pharmacol; 2007 Dec; 72(6):1607-18. PubMed ID: 17855652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Jun N-terminal kinase pathway activation in human and experimental cerebral contusion.
    Ortolano F; Colombo A; Zanier ER; Sclip A; Longhi L; Perego C; Stocchetti N; Borsello T; De Simoni MG
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):964-71. PubMed ID: 19680147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IKappaB-kinase/nuclear factor-kappaB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation.
    Chen LW; Chen PH; Chang WJ; Wang JS; Karin M; Hsu CM
    Crit Care Med; 2007 May; 35(5):1332-40. PubMed ID: 17414734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis.
    Bozyczko-Coyne D; O'Kane TM; Wu ZL; Dobrzanski P; Murthy S; Vaught JL; Scott RW
    J Neurochem; 2001 May; 77(3):849-63. PubMed ID: 11331414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults.
    Maroney AC; Finn JP; Bozyczko-Coyne D; O'Kane TM; Neff NT; Tolkovsky AM; Park DS; Yan CY; Troy CM; Greene LA
    J Neurochem; 1999 Nov; 73(5):1901-12. PubMed ID: 10537048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Jun N-Terminal Kinase Signaling Inhibitors Under Development.
    Han SY
    Toxicol Res; 2008 Jun; 24(2):93-100. PubMed ID: 32038782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of JNK-dependent and -independent components of cerebellar granule neuron apoptosis.
    Harris C; Maroney AC; Johnson EM
    J Neurochem; 2002 Nov; 83(4):992-1001. PubMed ID: 12421372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycyrrhetinic acid induces cytoprotective autophagy via the inositol-requiring enzyme 1α-c-Jun N-terminal kinase cascade in non-small cell lung cancer cells.
    Tang ZH; Zhang LL; Li T; Lu JH; Ma DL; Leung CH; Chen XP; Jiang HL; Wang YT; Lu JJ
    Oncotarget; 2015 Dec; 6(41):43911-26. PubMed ID: 26549806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.